364 related articles for article (PubMed ID: 26634567)
1. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
Chen SS; Sheth H; Piraino B; Bender F
Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
[TBL] [Abstract][Full Text] [Related]
2. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
[TBL] [Abstract][Full Text] [Related]
4. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
[TBL] [Abstract][Full Text] [Related]
7. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
Tsai CC; Yang PS; Liu CL; Wu CJ; Hsu YC; Cheng SP
Am J Surg; 2018 Jan; 215(1):179-185. PubMed ID: 28341139
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections.
Chu KH; Choy WY; Cheung CC; Fung KS; Tang HL; Lee W; Cheuk A; Yim KF; Chan WH; Tong KL
Perit Dial Int; 2008; 28(5):505-8. PubMed ID: 18708544
[TBL] [Abstract][Full Text] [Related]
9. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.
Pierce DA; Williamson JC; Mauck VS; Russell GB; Palavecino E; Burkart JM
Perit Dial Int; 2012; 32(5):525-30. PubMed ID: 22302770
[TBL] [Abstract][Full Text] [Related]
10. Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey.
Kopriva-Altfahrt G; König P; Mündle M; Prischl F; Roob JM; Wiesholzer M; Vychytil A; ; Arneitz K; Karner A; Artes R; Wolf E; Auinger M; Pawlak A; Fraberger J; Hofbauer S; Galvan G; Salmhofer H; Pichler B; Wazel M; Gruber M; Thonhofer A; Hager A; Malajner S; Heiss S; Braunsteiner T; Zweiffler M; König P; Rudnicki M; Kogler R; Kohlhauser D; Wiesinger T; Kopriva-Altfahrt G; Moser E; Kotanko P; Loibner H; Nitz H; Miska HJ; Wenzel R; Wölfer M; Mündle M; Breuss H; Hölzl B; Prischi F; Schmekal B; Riener EM; Roob JM; Wonisch W; Vikydal R; Vychytil A; Frank B; Wieser C; Wiesholzer M; Pokorny K
Perit Dial Int; 2009; 29(3):330-9. PubMed ID: 19458307
[TBL] [Abstract][Full Text] [Related]
11. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
[TBL] [Abstract][Full Text] [Related]
14. [Importance of exit site care as peritonitis prophylaxis: experience in our centre].
Conde Rivera O; Santos Nores J; Borrajo Prol M; Pérez Melón C
Nefrologia; 2010; 30(5):589-91. PubMed ID: 20882098
[No Abstract] [Full Text] [Related]
15. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
McQuillan RF; Chiu E; Nessim S; Lok CE; Roscoe JM; Tam P; Jassal SV
Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
[TBL] [Abstract][Full Text] [Related]
16. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
Ritzau J; Hoffman RM; Tzamaloukas AH
Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
[TBL] [Abstract][Full Text] [Related]
17. Erosion of the Silicone Peritoneal Dialysis Catheter with the Use of Gentamicin Cream at the Exit Site.
Gardezi AI; Schlageter KW; Foster DM; Astor BC; Chan MR; Waheed S
Adv Perit Dial; 2016; 32():15-18. PubMed ID: 28988584
[TBL] [Abstract][Full Text] [Related]
18. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial.
Restrepo C; Chacon J; Manjarres G
Perit Dial Int; 2010; 30(6):619-25. PubMed ID: 20634438
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
Sachar M; Shah A
Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
[TBL] [Abstract][Full Text] [Related]
20. Prevention of peritonitis in peritoneal dialysis.
Segal JH; Messana JM
Semin Dial; 2013; 26(4):494-502. PubMed ID: 23859192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]